Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-014208
Filing Date
2025-09-19
Accepted
2025-09-19 15:16:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4972
  Complete submission text file 0001493152-25-014208.txt   6942
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Subject) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-52381 | Film No.: 251326534
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139
Business Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139 786-381-2877
Lincoln Alternative Strategies LLC (Filed by) CIK: 0002043812 (see all company filings)

EIN.: 991727271 | State of Incorp.: DE | Fiscal Year End: 0324
Type: SCHEDULE 13G